drugset / Trial / NCT01174264

Evaluation of Food Effect on Pharmacokinetics of Vismodegib

NCT01174264 ↗

Phase 1/2 Completed 63 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized clinical trial studies the effect of food on the pharmacokinetics of vismodegib. Studying the effects of meals on the absorption of vismodegib may help doctors prescribe correct doses and label the drug accurately.

Timeline

Start
2009-10
Primary completion
2014-12
Completion
2014-12

Outcome

Mixed primary results

registry Arm I (Vismodegib on Empty Stomach) vs Arm II (Vismodegib After High Fat Meal); p = 0.003; Ratio of geometric means 1.75 (90% CI 1.30 to 2.34) NCT01174264 ↗

registry Arm I (Vismodegib on Empty Stomach) vs Arm II (Vismodegib After High Fat Meal); p = 0.008; Ratio of geometric means 1.74 (90% CI 1.25 to 2.42) NCT01174264 ↗

registry Arm I (Vismodegib on Empty Stomach) vs Arm III (Vismodegib After Low Fat Meal); p = 0.65; Ratio of geometric means 1.08 (90% CI 0.81 to 1.44) NCT01174264 ↗

registry Arm I (Vismodegib on Empty Stomach) vs Arm III (Vismodegib After Low Fat Meal); p = 0.51; Ratio of geometric means 1.12 (90% CI 0.84 to 1.49) NCT01174264 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Vismodegib Small molecule — Oral

Indications